VAERS 2615047
SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ635AAA
- Staat
- MA
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 14.04.2023
- Impfdatum
- 21.06.2022
- Beginn
- 21.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Symptomtext
extra dose administered with no reported AE; Initial information received on 11-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2023SA113854. This case involves a 7 years old male patient who was administered an extra dose of HIB (PRP/T) VACCINE [ACT-HIB] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 21-Jun-2022, the patient received 0.5 ml of suspect HIB (PRP/T) Vaccine Powder and solvent for solution for injection (lot number: UJ635AAA; Expiry date: 30-NOV-2022) (Strength: Standard; Frequency: utr) via intramuscular route in unknown administration site for immunisation. On 21-Jun-2022 the patient was administered an extra dose of HIB (PRP/T) VACCINE with no reported adverse event (extra dose administered) (Latency: same day). It was reported, Nurse has questions on how to proceed. She states the PENTACEL components were all given separately and an extra dose was given by accident. Call transferred. The nurse states that their clinic did not receive the immunization records on a new patient until after extra doses of DAPTACEL, IPOL, and ACTHIB were given in error. Extra dose of ACTHIB given on 21Jun2022. The nurse asks if these are valid doses or should they be reinjected. The HCP asks if the patient will experience any AE's as a result of this Action taken: not applicable. At time of reporting, the outcome was Unknown for the event extra dose administered with no reported ae. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -